Image via Wikipedia
Medicare just started reimbursing doctors less for very small amounts of the cancer drug Avastin. Oddly enough, that could mean Medicare will start spending lots more money on the eye drug Lucentis. Here’s why.
Continue Reading
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_b.png?x-id=5a70a841-320e-4a27-9ee6-7efa128c353e)
Friday, October 2, 2009
How Cutting Payments for a Drug Could Cost Medicare More - Health Blog - WSJ
Medicare just started reimbursing doctors less for very small amounts of the cancer drug Avastin. Oddly enough, that could mean Medicare will start spending lots more money on the eye drug Lucentis. Here’s why.
Continue Reading
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment